Advertisement
Cellular Research
Cellular Research

The Scientist

» pharmaceuticals and evolution

Most Recent

image: Spinoff Company to Develop Rare Disease Drugs

Spinoff Company to Develop Rare Disease Drugs

By | January 7, 2015

Maryland-based Vtesse will work with the US National Institutes of Health to advance treatments for Niemann-Pick Type C disease and other lysosomal storage disorders.

1 Comment

image: Contributors

Contributors

By | January 1, 2015

Meet some of the people featured in the January 2015 issue of The Scientist.

0 Comments

image: Performance Art

Performance Art

By | January 1, 2015

Regulation of genome expression orchestrates the behavior of insect castes and the human response to social stress.

0 Comments

image: Why, Oh Y?

Why, Oh Y?

By | January 1, 2015

A toothpick and a bit of chance shaped David Page’s career, which he has dedicated to understanding the mammalian Y chromosome and fetal germ cell development.

0 Comments

image: The Genetics of Society

The Genetics of Society

By | January 1, 2015

Researchers aim to unravel the molecular mechanisms by which a single genotype gives rise to diverse castes in eusocial organisms.

8 Comments

image: Unraveling H7N9’s History

Unraveling H7N9’s History

By | December 30, 2014

An analysis of stored samples shows that H7N9 precursor H9N2, a virus widespread in chickens, has shown increased fitness in recent years.

0 Comments

image: Behavior Brief

Behavior Brief

By | December 18, 2014

A round-up of recent discoveries in behavior research

0 Comments

image: Iron-Ferrying Protein Impedes Pathogens

Iron-Ferrying Protein Impedes Pathogens

By | December 15, 2014

Meningitis-causing bacteria exerted strong evolutionary pressure on an iron-binding protein in primates, a study shows.

0 Comments

image: Bird Genomes Abound

Bird Genomes Abound

By | December 11, 2014

Scientists complete the largest-ever comparative genomic study of birds.

1 Comment

image: Merck Buys Cubist for $8.4B

Merck Buys Cubist for $8.4B

By | December 11, 2014

Hours after the pharmaceutical giant announced the acquisition, a federal judge invalidated key patents behind the antibiotic maker’s most lucrative product.

0 Comments

Advertisement

Popular Now

  1. Opinion: Making Progress by Slowing Down
  2. How Fats Influence the Microbiome
  3. Censored Professor Quits
    The Nutshell Censored Professor Quits

    Alice Dreger is resigning from the faculty of Northwestern University, claiming that the administration censored her work in a faculty journal.

  4. Influential Cancer Biologist Dies
Advertisement
Advertisement
Life Technologies